CN103142848A - 一种抗衰老中药制剂及其制备方法 - Google Patents
一种抗衰老中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN103142848A CN103142848A CN2013100372616A CN201310037261A CN103142848A CN 103142848 A CN103142848 A CN 103142848A CN 2013100372616 A CN2013100372616 A CN 2013100372616A CN 201310037261 A CN201310037261 A CN 201310037261A CN 103142848 A CN103142848 A CN 103142848A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- radix
- chinese medicine
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 83
- 238000002360 preparation method Methods 0.000 title claims abstract description 48
- 230000003712 anti-aging effect Effects 0.000 title abstract description 8
- 229940079593 drug Drugs 0.000 claims abstract description 60
- 230000032683 aging Effects 0.000 claims abstract description 34
- 241000208340 Araliaceae Species 0.000 claims abstract description 24
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 24
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 24
- 235000008434 ginseng Nutrition 0.000 claims abstract description 24
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 15
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 15
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 3
- 238000002156 mixing Methods 0.000 claims description 25
- 235000012907 honey Nutrition 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 18
- 239000006187 pill Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 239000004615 ingredient Substances 0.000 claims description 12
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 11
- 238000004140 cleaning Methods 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 238000004898 kneading Methods 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 241000270290 Gekkota Species 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 238000009413 insulation Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 33
- 210000004369 blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 14
- 210000003734 kidney Anatomy 0.000 abstract description 14
- 239000002994 raw material Substances 0.000 abstract description 14
- 210000004185 liver Anatomy 0.000 abstract description 12
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 210000002216 heart Anatomy 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 6
- 208000009205 Tinnitus Diseases 0.000 abstract description 5
- 231100000886 tinnitus Toxicity 0.000 abstract description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 3
- 206010003549 asthenia Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 208000002173 dizziness Diseases 0.000 abstract description 3
- 201000001881 impotence Diseases 0.000 abstract description 3
- 206010022437 insomnia Diseases 0.000 abstract description 3
- 210000003127 knee Anatomy 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 206010029410 night sweats Diseases 0.000 abstract description 2
- 230000036565 night sweats Effects 0.000 abstract description 2
- 238000005457 optimization Methods 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 230000002936 tranquilizing effect Effects 0.000 abstract description 2
- 239000000470 constituent Substances 0.000 abstract 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000209020 Cornus Species 0.000 abstract 1
- 241000759833 Cornus officinalis Species 0.000 abstract 1
- 241001632410 Eleutherococcus senticosus Species 0.000 abstract 1
- 244000119298 Emblica officinalis Species 0.000 abstract 1
- 235000015489 Emblica officinalis Nutrition 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 208000007443 Neurasthenia Diseases 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 206010041497 Spermatorrhoea Diseases 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000021049 nutrient content Nutrition 0.000 abstract 1
- 241000218628 Ginkgo Species 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 239000009609 fructus phyllanthi Substances 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 230000003064 anti-oxidating effect Effects 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 241000205407 Polygonum Species 0.000 description 5
- 210000000748 cardiovascular system Anatomy 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- -1 lipid peroxide Chemical class 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 206010039966 Senile dementia Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 2
- 102000009571 Macrophage Inflammatory Proteins Human genes 0.000 description 2
- 108010009474 Macrophage Inflammatory Proteins Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940025084 amphetamine Drugs 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000002180 anti-stress Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000002960 bfu-e Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000003013 erythroid precursor cell Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000000971 hippocampal effect Effects 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000008929 jingui shenqi Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000001625 seminal vesicle Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 201000010653 vesiculitis Diseases 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010061164 Gastric mucosal lesion Diseases 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 102000010909 Monoamine Oxidase Human genes 0.000 description 1
- 108010062431 Monoamine oxidase Proteins 0.000 description 1
- 102000006538 Nitric Oxide Synthase Type I Human genes 0.000 description 1
- 108010008858 Nitric Oxide Synthase Type I Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010003541 Platelet Activating Factor Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000001466 anti-adreneric effect Effects 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000027326 copulation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 210000001357 hemopoietic progenitor cell Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000005184 irreversible process Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical group 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 108010017843 platelet-derived growth factor A Proteins 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310037261.6A CN103142848B (zh) | 2013-01-30 | 2013-01-30 | 一种抗衰老中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310037261.6A CN103142848B (zh) | 2013-01-30 | 2013-01-30 | 一种抗衰老中药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103142848A true CN103142848A (zh) | 2013-06-12 |
CN103142848B CN103142848B (zh) | 2014-11-26 |
Family
ID=48541357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310037261.6A Expired - Fee Related CN103142848B (zh) | 2013-01-30 | 2013-01-30 | 一种抗衰老中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103142848B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103829201A (zh) * | 2014-03-05 | 2014-06-04 | 哈尔滨灵椿味道食品开发有限公司 | 一种灵芝滋补强身火锅料及生产方法 |
CN106491746A (zh) * | 2016-11-30 | 2017-03-15 | 四川旭华制药有限公司 | 一种抗衰老中药组合物 |
CN106822829A (zh) * | 2016-12-30 | 2017-06-13 | 李日强 | 防老养生精 |
CN107029167A (zh) * | 2017-04-17 | 2017-08-11 | 毕长红 | 一种养血安神、抗衰防痴中药制剂及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1097998A (zh) * | 1993-07-24 | 1995-02-01 | 高风兰 | 生力养生液 |
CN101381668A (zh) * | 2008-09-18 | 2009-03-11 | 何官平 | 一种保健药酒的制备方法 |
CN101804165A (zh) * | 2010-04-16 | 2010-08-18 | 武汉枫叶红生物科技有限公司 | 一种清肾毒,强健五脏六腑,增强体质延缓衰老的制剂及其制备方法 |
-
2013
- 2013-01-30 CN CN201310037261.6A patent/CN103142848B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1097998A (zh) * | 1993-07-24 | 1995-02-01 | 高风兰 | 生力养生液 |
CN101381668A (zh) * | 2008-09-18 | 2009-03-11 | 何官平 | 一种保健药酒的制备方法 |
CN101804165A (zh) * | 2010-04-16 | 2010-08-18 | 武汉枫叶红生物科技有限公司 | 一种清肾毒,强健五脏六腑,增强体质延缓衰老的制剂及其制备方法 |
Non-Patent Citations (2)
Title |
---|
曾秀池: "中药抗衰老机理浅识", 《实用中医药杂志》, vol. 22, no. 11, 31 December 2006 (2006-12-31), pages 712 - 713 * |
覃骊兰,杨丽琴: "延缓衰老复方用药规律的研究", 《吉林中医药》, vol. 31, no. 8, 31 December 2011 (2011-12-31), pages 803 - 805 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103829201A (zh) * | 2014-03-05 | 2014-06-04 | 哈尔滨灵椿味道食品开发有限公司 | 一种灵芝滋补强身火锅料及生产方法 |
CN103829201B (zh) * | 2014-03-05 | 2015-07-15 | 哈尔滨灵椿味道食品开发有限公司 | 一种灵芝滋补强身火锅料及生产方法 |
CN106491746A (zh) * | 2016-11-30 | 2017-03-15 | 四川旭华制药有限公司 | 一种抗衰老中药组合物 |
CN106822829A (zh) * | 2016-12-30 | 2017-06-13 | 李日强 | 防老养生精 |
CN107029167A (zh) * | 2017-04-17 | 2017-08-11 | 毕长红 | 一种养血安神、抗衰防痴中药制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103142848B (zh) | 2014-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101513437B (zh) | 一种抗疲劳中药组合物及其制备方法 | |
CN102784295B (zh) | 一种改善女性更年期综合症的保健制剂配方及其制备方法 | |
CN101804165B (zh) | 一种清肾毒,强健五脏六腑,增强体质延缓衰老的制剂及其制备方法 | |
CN1170588A (zh) | 一种纯天然植物人体生命核能营养基质 | |
CN112121144B (zh) | 一种刺梨组合物及其制备方法和用途 | |
CN103719498A (zh) | 一种提高免疫力的黄精保健茶及其制备方法 | |
CN107853517B (zh) | 一种提神抗疲劳的中药饮料及其制备方法 | |
CN103142848B (zh) | 一种抗衰老中药制剂及其制备方法 | |
CN112933203A (zh) | 一种抗疲劳改善性功能药酒的中药组合物及其制备方法 | |
CN105995399A (zh) | 调节人体亚健康的药膳粉 | |
CN103719493A (zh) | 一种补脑益智的黄精保健茶及其制备方法 | |
KR20100036820A (ko) | 생약재를 주재로 한 환제 정력보강식품 및 그 제조방법 | |
CN108887544A (zh) | 一种天然养生饮料 | |
CN101152359A (zh) | 一种保健药酒及其制造方法 | |
CN104489172A (zh) | 一种提高免疫力的刺五加保健茶及其制备方法 | |
KR20100077781A (ko) | 발기부전에 효과적인 기능성 분말의 제조 방법, 이에 의한 기능성 분말을 포함하는 기능성 보조식품 | |
CN104547598A (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN104397282A (zh) | 一种安神补脑的刺五加保健茶及其制备方法 | |
CN110538308B (zh) | 一种生发的中药组合物及其制备方法 | |
CN113456778A (zh) | 一种提升能量的组合物及其制备方法 | |
CN114081171A (zh) | 一种具有辅助改善睡眠作用的功能性食品组合物 | |
CN106360716A (zh) | 一种同时改善机体免疫力和睡眠的中药组合物及其制备方法 | |
CN102250736B (zh) | 一种保健药酒及其制造方法 | |
CN105582334A (zh) | 全植物保健品 | |
CN102266427A (zh) | 一种用于美容养颜的鹿茸当归酒及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: JIN CHENGLIE ZHUANG LINGLING BI CHANGHONG FENG LI Free format text: FORMER OWNER: BI CHANGHONG FENG LI JIN RENZHE ZHUANG SHUFAN Effective date: 20140905 Owner name: ZHUANG SHUFAN Free format text: FORMER OWNER: JIN CHENGLIE Effective date: 20140905 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhuang Shufan Inventor after: Jin Chenglie Inventor after: Zhuang Lingling Inventor after: Bi Changhong Inventor after: Feng Li Inventor after: Jin Renzhe Inventor before: Jin Chenglie Inventor before: Bi Changhong Inventor before: Feng Li Inventor before: Jin Renzhe Inventor before: Zhuang Shufan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: JIN CHENGLIE BI CHANGHONG FENG LI JIN RENZHE ZHUANG SHUFAN TO: ZHUANG SHUFAN JIN CHENGLIE ZHUANG LINGLING BI CHANGHONG FENG LI JIN RENZHE Free format text: CORRECT: ADDRESS; FROM: 133100 YANBIAN KOREAN AUTONOMOUS PREFECTURE, JILIN PROVINCE TO: 518000 SHENZHEN, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140905 Address after: 2 2 unit 14D, sunshine rose garden, former route, Nanshan District, Guangdong, Shenzhen 518000, China Applicant after: Zhuang Shufan Applicant after: Jin Chenglie Applicant after: Zhuang Lingling Applicant after: Bi Changhong Applicant after: Feng Li Applicant after: Jin Renzhe Address before: 133100, Jilin, Yanbian Korean Autonomous Prefecture, Xinhua Street, Tumen, fifteen Committee of the eight group Applicant before: Jin Chenglie Applicant before: Bi Changhong Applicant before: Feng Li Applicant before: Jin Renzhe Applicant before: Zhuang Shufan |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160406 Address after: Longgang District of Shenzhen City, Guangdong province 518172 Dragon Street lime Wai Road No. 12 Patentee after: Shenzhen million Wanglong Biotechnology Co. Ltd. Address before: 2 2 unit 14D, sunshine rose garden, former route, Nanshan District, Guangdong, Shenzhen 518000, China Patentee before: Zhuang Shufan Patentee before: Jin Chenglie Patentee before: Zhuang Lingling Patentee before: Bi Changhong Patentee before: Feng Li Patentee before: Jin Renzhe |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141126 Termination date: 20190130 |